Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Surveillance of vaccine-preventable diseases (VPDs ): Update 2017 : Bacterial VPDs
  • Published Date:
    December 5, 2017
  • Language:
    English
Filetype[PDF-4.60 MB]


Details:
  • Description:
    Session II: CDC subject matter experts for bacterial VPDs (meningococcal disease, pertussis, invasive pneumococcal disease, Haemophilus influenzae, and diphtheria)

    Bacterial.pdf

  • Document Type:
    Presentation
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Main Document Checksum:
    1. Surveillance of vaccine-preventable diseases (VPDs ): Update 2017 : Viral VPDs
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Centers for Disease Control and Prevention. Office of the Associate Director for Communications. Division of Public Affairs..
      Published Date:
      November 28, 2017
      Description:
      Session I: CDC subject matter experts for viral VPDs (mumps, acute flaccid myelitis/polio, varicella, measles, and rotavirus)Viral%20slies.pdf
      File Type:
      Filetype[PDF - 6.24 MB]
You May Also Like:
  1. Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms
    Personal Author:
    Mulders, Mick N.; Serhan, Fatima; Goodson, James L.; Icenogle, Joseph; Johnson, Barbara W.; Rota, Paul A.;
    Published Date:
    Jul 01 2017
    Source:
    J Infect Dis. 2017; 216(Suppl 1):S324-S330.
    Description:
    Laboratory networks were established to provide accurate and timely laboratory confirmation of infections, an essential component of disease surveillance systems. The World Health Organization (WHO) coordinates global laboratory surveillance of vacci...
    File Type:
    Filetype[PDF - 1.66 MB]
  2. Surveillance of vaccine-preventable diseases (VPDs ): Update 2017 : Viral VPDs
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Centers for Disease Control and Prevention. Office of the Associate Director for Communications. Division of Public Affairs..
    Published Date:
    November 28, 2017
    Description:
    Session I: CDC subject matter experts for viral VPDs (mumps, acute flaccid myelitis/polio, varicella, measles, and rotavirus)Viral%20slies.pdf
    File Type:
    Filetype[PDF - 6.24 MB]
  3. Using Acute Flaccid Paralysis Surveillance as a Platform for Vaccine-Preventable Disease Surveillance
    Personal Author:
    Wassilak, Steven G. F.; Williams, Cheryl L.; Murrill, Christopher S.; Dahl, Benjamin A.; Ohuabunwo, Chima; Tangermann, Rudolf H.;
    Published Date:
    Jul 01 2017
    Source:
    J Infect Dis. 2017; 216(Suppl 1):S293-S298.
    Description:
    Surveillance for acute flaccid paralysis (AFP) is a fundamental cornerstone of the global polio eradication initiative (GPEI). Active surveillance (with visits to health facilities) is a critical strategy of AFP surveillance systems for highly sensit...
    File Type:
    Filetype[PDF - 111.28 KB]
  4. CDC’s strategic framework for global immunization, 2016–2020
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Global Health (U.S.). Global Immunization Division..
    Published Date:
    May 2016
    Description:
    • Vision and Mission• Foreword• Overview• Background• Strategic Framework Goals, Priorities, and Objectives:o GOAL 1: Control, eliminate, or eradicate vaccine-preventable diseases to reduce death and disability globallyo GOAL 2: Strengthen ...
    File Type:
    Filetype[PDF - 2.18 MB]
  5. Global immunization strategic framework; 2006-2010
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.), Global Immunization Division.
    Published Date:
    2007
    Description:
    "Since 1991, CDC has provided substantial financial and technical support for polio eradication and measles elimination. CDC's yearly investment in global immunization has grown from $3.1 million to $140 million in 2006. In addition, CDC currently ha...
    File Type:
    Filetype[PDF - 457.71 KB]